Article Details
Retrieved on: 2021-03-31 20:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Patients with COVID-19 and cancer may benefit from a combination of monoclonal antibodies that target the spike protein rather than a single-agent ...
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here